Meditation app eases anxiety in uveitis patients
NCT ID NCT06585670
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a smartphone meditation app (Calm Health) could help reduce anxiety and depression in 100 adults with non-infectious uveitis, an inflammatory eye disease. Participants used the app and reported their symptoms. The goal was to see if digital mindfulness can improve mental health and vision-related quality of life.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
100 people
The number who actually took part.
- Started
-
Aug 2024
- Finished
-
Aug 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Is 18 or older at time of enrollment. * Is willing to download Calm Health on their smartphone * Is able to operate a smartphone \& Calm Health without assistance * Is able to read words on a screen without assistance * Diagnosis of non-infectious uveitis Exclusion Criteria: * Is under 18 at time of enrollment. * Has started taking a new anti-depressant, anti-anxiety, or other psychiatric medication to improve mood within the past month. * Plans to start taking a new anti-depressant, anti-anxiety, or other psychiatric medication to improve mood in the next 12 weeks. * Has started any type of psychotherapy within the past 3 months. * Plans to start any type of psychotherapy within the next 12 weeks. * Already has a mindfulness/meditation app on their smartphone. * Is unable to operate a smartphone or read words on a screen without assistance. * Is unable or unwilling to download the Calm Health app on their smartphone. * Does not consent to their anonymized data being collected via Calm Health app.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Non-infectious uveitis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UCSF
San Francisco, California, 94158, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.